文献速递血栓与止血

单细胞解析ANKRD26血小板减少症:祖细胞扩增与多倍体凋亡经JUNB-p21通路

Single-cell profiling of ANKRD26 thrombocytopenia reveals progenitor expansion and polyploid apoptosis via JUNB-p21.
PubMed 文献 · Blood · 2026-01-01

该研究对4例ANKRD26相关血小板减少症2型(THC2)患者的骨髓样本进行单细胞转录组和离体功能分析,发现巨核祖细胞扩增而多倍体巨核细胞显著减少。机制上,ANKRD26升高通过JUNB介导的CDKN1A(p21)转录激活诱导多倍体巨核细胞凋亡,不依赖经典p53-PIDDosome轴。

要点

  • THC2患者骨髓显示巨核祖细胞扩增和多倍体巨核细胞减少。
  • ANKRD26定位于中心体,可能参与巨核细胞成熟中的有丝分裂调控。
  • ANKRD26通过JUNB-p21轴诱导多倍体巨核细胞凋亡,不依赖p53通路。

核心结论

  • THC2患者骨髓呈现巨核祖细胞扩增和多倍体巨核细胞减少的保守病理表型。
  • ANKRD26升高通过JUNB介导的p21转录激活诱导多倍体巨核细胞凋亡。

研究设计与样本

  • 对4例独立THC2患者的骨髓样本进行单细胞转录组和离体功能分析。
  • 分析CD34+造血干祖细胞(THC2 47 281个 vs 对照51 907个)和原代巨核细胞(THC2 7309个 vs 对照5077个)。

主要发现

  • 在所有患者中均观察到巨核祖细胞扩增和多倍体巨核细胞显著减少。
  • 在索引患者中鉴定出ANKRD26 5'UTR单核苷酸变异,导致4个巨核谱系亚群及终末富集原代巨核细胞中表达显著升高。
  • 共聚焦成像显示ANKRD26定位于中心体。
  • ANKRD26升高通过JUNB介导的CDKN1A(p21)转录激活诱导多倍体巨核细胞凋亡,不依赖经典p53-PIDDosome轴。

临床怎么用

  • THC2的巨核祖细胞扩增和多倍体减少可作为潜在病理标志。
  • JUNB-p21轴可能成为恢复血小板生成的候选治疗靶点。

局限性

  • 样本量小(4例患者),结果需更大队列验证。
  • 机制研究主要在索引患者中展开,患者间异质性可能影响普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ANKRD26-related thrombocytopenia 2 (THC2) is a rare inherited platelet disorder caused by germ line variants in the 5' untranslated region (UTR) of ANKRD26. Although prior studies using in vitro models or isolated case reports have suggested impaired megakaryopoiesis as a central mechanism, detailed insights have remained elusive, primarily due to the rarity, fragility, and heterogeneity of megakaryocytes (MKs). Here, we present a comprehensive, crossvalidated analysis of bone marrow samples from 4 independent patients with THC2, integrating single-cell transcriptomics and ex vivo functional profiling. Across all patients, we analyzed CD34+ hematopoietic stem and progenitor cells (HSPCs; 47 281 THC2 HSPCs vs 51 907 control cells) and primary MKs (pMKs; 7309 THC2 pMKs vs 5077 control cells), uncovering a consistent pattern of MK progenitors (MkP) expansion and a marked reduction in polyploid MKs, indicating a conserved pathophysiologic phenotype. In our index patient, we identified the 5' UTR single-nucleotide variant in ANKRD26 that led to significantly elevated expression across 4 MK lineage subsets, spanning multipotent progenitors, common myeloid progenitors, MK-erythroid progenitors, and MkP as well as in terminally enriched pMKs. Confocal imaging localized ANKRD26 to the centrosome, implicating it in mitotic regulation during MK maturation. Mechanistically, we discovered that elevated ANKRD26 induces apoptosis in polyploid MKs via JUNB-mediated transcriptional activation of CDKN1A (p21), operating independently of the canonical p53-PIDDosome axis. This multipatient study provided the most comprehensive cellular and molecular portrait of ANKRD26-driven thrombocytopenia to date, offering novel insights into defective megakaryopoiesis and identifying candidate therapeutic targets to restore platelet production.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Chen L, Hu L, Liu X, et al. Single-cell profiling of ANKRD26 thrombocytopenia reveals progenitor expansion and polyploid apoptosis via JUNB-p21. Blood. 2026. PMID: 41538704. doi:10.1182/blood.2025030017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。